SCOR Global Life: The impact of different screening scenerios on breast cancer incidenceSeptember 8 2015
The trend of cancer incidences is one of the key questions for developing critical illness (CI) and cancer insurance products with a sustainable price.
One of the identified (risk) factors is the availability and/or introduction of screening programs for cancer, which will impact the level of detection of early cancers and can lead to strong increases in incidences. Among the common cancer screenings available, breast cancer is one of the key cancer types, representing around 25% of all female cancer incidences.
In cooperation with the Department of Public Health of the Erasmus Medical Center University, a leading institute on modelling cancer screening effects, SCOR Global Life gives a deeper insight on the effect of breast cancer screening.
The results from this work give a deeper insight into the risk of changes in screening practice both from a forward looking perspective for countries without existing screening programs and retroactively to understand population data and claims experience not only in the Netherlands and on breast cancer but also worldwide with a more general view on products where breast cancer is only one of many covered conditions.
- August 20
The move comes as the broking group's MGA division acquires AIG's HNW home and contents portfolio.
- July 2
The Asia chief executive discusses Covid-19, going digital and restructuring.
- April 10
Climate change, increased urbanisation and a growing concentration of assets were on the risk agenda for 2018.
- March 19
Economic uncertainty, more complex risks and tighter underwriting are all influencing Asia's markets.
A longer claims process and increased cost were some of the challenges faced by insurers.
Tropical cyclones have always been a significant peril in Asia and a major focus for risk assessment in the region.